CovidChloroV1, Main, Corpus, bibRecord, 000E65

Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.

Identifieur interne : 000E65 ( Main/Corpus ); précédent : 000E64; suivant : 000E66

Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.

Auteurs : Faryal I. Farooqi ; Richard C. Morgan ; Naveen Dhawan ; John Dinh ; George Yatzkan ; George Michel

Source :

The American journal of case reports [ 1941-5923 ] ; 2020.

RBID : pubmed:32810081

English descriptors

KwdEn :
- Aged (MeSH), Antimalarials (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (therapy), Coronavirus Infections (transmission), Critical Illness (therapy), Disease Transmission, Infectious (prevention & control), Humans (MeSH), Hydroxychloroquine (therapeutic use), Hygiene (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (therapy), Pneumonia, Viral (transmission), Respiration, Artificial (methods), SARS-CoV-2 (MeSH), Ships (MeSH).
MESH :
- chemical , therapeutic use : Antimalarials, Hydroxychloroquine.
- methods : Respiration, Artificial.
- prevention & control : Disease Transmission, Infectious.
- therapy : Coronavirus Infections, Critical Illness, Pneumonia, Viral.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Aged, Betacoronavirus, COVID-19, Humans, Hygiene, Male, Middle Aged, Pandemics, SARS-CoV-2, Ships.

Abstract

BACKGROUND COVID-19, the disease entity caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2), continues to pose a major therapeutic challenge for clinicians. At present, an effective treatment regimen and vaccination has not been established. Many patients develop severe symptoms requiring endotracheal intubation and a prolonged stay in the Intensive Care Unit (ICU). In early postmortem examinations of COVID-19 patients, profuse viscous secretions were observed throughout the respiratory tract. Thus, oxygen supplementation without aggressive pulmonary hygiene management may be suboptimal. In the present case series, pulmonary hygiene management encompassed mucolytics, bronchodilators, and tracheal suctioning. We report 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management. CASE REPORT Three cruise ship employees with COVID-19 underwent endotracheal intubation and were admitted to the ICU for acute hypoxemic respiratory failure. Initial chest X-rays suggested multifocal pneumonia with superimposed acute respiratory distress syndrome (ARDS). A regimen of hydroxychloroquine, azithromycin, and dexamethasone was initiated on admission in all cases. Additionally, medications used for pulmonary hygiene were administered through a metered-dose inhaler (MDI) in line with the ventilator circuit. Endotracheal suctioning was performed prior to medication administration. The duration from endotracheal intubation to extubation ranged from 9 to 24 days. All 3 patients reached 30-day survival. CONCLUSIONS The cases reported highlight the importance of the use of airway hygiene with mucolytics, bronchodilators, and tracheal suctioning for patients with COVID-19 pneumonia requiring ventilatory support.

DOI: 10.12659/AJCR.926596
PubMed: 32810081
PubMed Central: PMC7458693

Links to Exploration step

pubmed:32810081

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.</title>
<author><name sortKey="Farooqi, Faryal I" sort="Farooqi, Faryal I" uniqKey="Farooqi F" first="Faryal I" last="Farooqi">Faryal I. Farooqi</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morgan, Richard C" sort="Morgan, Richard C" uniqKey="Morgan R" first="Richard C" last="Morgan">Richard C. Morgan</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dhawan, Naveen" sort="Dhawan, Naveen" uniqKey="Dhawan N" first="Naveen" last="Dhawan">Naveen Dhawan</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dinh, John" sort="Dinh, John" uniqKey="Dinh J" first="John" last="Dinh">John Dinh</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yatzkan, George" sort="Yatzkan, George" uniqKey="Yatzkan G" first="George" last="Yatzkan">George Yatzkan</name>
<affiliation><nlm:affiliation>Department of Critical Care Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Michel, George" sort="Michel, George" uniqKey="Michel G" first="George" last="Michel">George Michel</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32810081</idno>
<idno type="pmid">32810081</idno>
<idno type="doi">10.12659/AJCR.926596</idno>
<idno type="pmc">PMC7458693</idno>
<idno type="wicri:Area/Main/Corpus">000E65</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E65</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.</title>
<author><name sortKey="Farooqi, Faryal I" sort="Farooqi, Faryal I" uniqKey="Farooqi F" first="Faryal I" last="Farooqi">Faryal I. Farooqi</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Morgan, Richard C" sort="Morgan, Richard C" uniqKey="Morgan R" first="Richard C" last="Morgan">Richard C. Morgan</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dhawan, Naveen" sort="Dhawan, Naveen" uniqKey="Dhawan N" first="Naveen" last="Dhawan">Naveen Dhawan</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dinh, John" sort="Dinh, John" uniqKey="Dinh J" first="John" last="Dinh">John Dinh</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yatzkan, George" sort="Yatzkan, George" uniqKey="Yatzkan G" first="George" last="Yatzkan">George Yatzkan</name>
<affiliation><nlm:affiliation>Department of Critical Care Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Michel, George" sort="Michel, George" uniqKey="Michel G" first="George" last="Michel">George Michel</name>
<affiliation><nlm:affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The American journal of case reports</title>
<idno type="eISSN">1941-5923</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Critical Illness (therapy)</term>
<term>Disease Transmission, Infectious (prevention & control)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Hygiene (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Respiration, Artificial (methods)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Ships (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Transmission, Infectious</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Critical Illness</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Hygiene</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
<term>Ships</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND COVID-19, the disease entity caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2), continues to pose a major therapeutic challenge for clinicians. At present, an effective treatment regimen and vaccination has not been established. Many patients develop severe symptoms requiring endotracheal intubation and a prolonged stay in the Intensive Care Unit (ICU). In early postmortem examinations of COVID-19 patients, profuse viscous secretions were observed throughout the respiratory tract. Thus, oxygen supplementation without aggressive pulmonary hygiene management may be suboptimal. In the present case series, pulmonary hygiene management encompassed mucolytics, bronchodilators, and tracheal suctioning. We report 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management. CASE REPORT Three cruise ship employees with COVID-19 underwent endotracheal intubation and were admitted to the ICU for acute hypoxemic respiratory failure. Initial chest X-rays suggested multifocal pneumonia with superimposed acute respiratory distress syndrome (ARDS). A regimen of hydroxychloroquine, azithromycin, and dexamethasone was initiated on admission in all cases. Additionally, medications used for pulmonary hygiene were administered through a metered-dose inhaler (MDI) in line with the ventilator circuit. Endotracheal suctioning was performed prior to medication administration. The duration from endotracheal intubation to extubation ranged from 9 to 24 days. All 3 patients reached 30-day survival. CONCLUSIONS The cases reported highlight the importance of the use of airway hygiene with mucolytics, bronchodilators, and tracheal suctioning for patients with COVID-19 pneumonia requiring ventilatory support.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32810081</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<PubDate><Year>2020</Year>
<Month>Aug</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of case reports</Title>
<ISOAbbreviation>Am J Case Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.</ArticleTitle>
<Pagination><MedlinePgn>e926596</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.926596</ELocationID>
<Abstract><AbstractText>BACKGROUND COVID-19, the disease entity caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2), continues to pose a major therapeutic challenge for clinicians. At present, an effective treatment regimen and vaccination has not been established. Many patients develop severe symptoms requiring endotracheal intubation and a prolonged stay in the Intensive Care Unit (ICU). In early postmortem examinations of COVID-19 patients, profuse viscous secretions were observed throughout the respiratory tract. Thus, oxygen supplementation without aggressive pulmonary hygiene management may be suboptimal. In the present case series, pulmonary hygiene management encompassed mucolytics, bronchodilators, and tracheal suctioning. We report 3 severe cases of COVID-19 pneumonia in cruise ship employees who were admitted to the ICU and responded to supportive mechanical ventilation and pulmonary hygiene management. CASE REPORT Three cruise ship employees with COVID-19 underwent endotracheal intubation and were admitted to the ICU for acute hypoxemic respiratory failure. Initial chest X-rays suggested multifocal pneumonia with superimposed acute respiratory distress syndrome (ARDS). A regimen of hydroxychloroquine, azithromycin, and dexamethasone was initiated on admission in all cases. Additionally, medications used for pulmonary hygiene were administered through a metered-dose inhaler (MDI) in line with the ventilator circuit. Endotracheal suctioning was performed prior to medication administration. The duration from endotracheal intubation to extubation ranged from 9 to 24 days. All 3 patients reached 30-day survival. CONCLUSIONS The cases reported highlight the importance of the use of airway hygiene with mucolytics, bronchodilators, and tracheal suctioning for patients with COVID-19 pneumonia requiring ventilatory support.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farooqi</LastName>
<ForeName>Faryal I</ForeName>
<Initials>FI</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morgan</LastName>
<ForeName>Richard C</ForeName>
<Initials>RC</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dhawan</LastName>
<ForeName>Naveen</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dinh</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yatzkan</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Critical Care Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Michel</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Internal Medicine, Larkin Community Hospital, South Miami, FL, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Am J Case Rep</MedlineTA>
<NlmUniqueID>101489566</NlmUniqueID>
<ISSNLinking>1941-5923</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018562" MajorTopicYN="N">Disease Transmission, Infectious</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006920" MajorTopicYN="Y">Hygiene</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012767" MajorTopicYN="Y">Ships</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32810081</ArticleId>
<ArticleId IdType="pii">926596</ArticleId>
<ArticleId IdType="doi">10.12659/AJCR.926596</ArticleId>
<ArticleId IdType="pmc">PMC7458693</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Crit Care. 2008;12(2):209</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18423061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(10):e48037</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23118923</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Res. 2020 Jul;157:104853</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32360584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Histopathology. 2020 May 4;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32364264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2020 Jun 1;217(6):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302401</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2019 Jul 3;2(7):e198116</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31365111</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2020 May 6;24(1):198</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32375845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Pathol. 2020 May 5;153(6):725-733</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32275742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Res. 2020 Jul;157:104837</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32334052</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2003 Jul;22(1):43-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12882449</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):221-236</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31987001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Respir Med. 2020 Jun;167:105951</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32421539</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 May;8(5):433-434</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32203709</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Iran J Med Sci. 2015 Jul;40(4):309-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26170516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2010 Dec 2;363(23):2233-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21121836</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2020 Jul;43(7):1382-1391</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2003 Sep;228(3):810-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12805557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care. 2020 Apr 16;24(1):154</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32299472</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32519944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Ther Med. 2017 Oct;14(4):2863-2868</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28928799</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1999 Jul;67(7):3267-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10377100</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2020 Jun 8;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32526193</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Aug;8(8):750-752</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32422177</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Intensive Care Med. 2020 Jun;46(6):1099-1102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32291463</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jun 11;382(24):2372-2374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302078</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Respir Care. 2020 Apr;65(4):545-557</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32213602</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 23;323(24):2518-2520</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32437497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Hypotheses. 2020 May 30;143:109862</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32504923</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Respir Med. 2020 Jul;8(7):681-686</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32473124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Pharmacol. 2010 Feb 1;79(3):413-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19732754</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trials. 2015 Sep 02;16:389</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26329352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Rep. 2019 Jul 18;39(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31273057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Jun;80(6):607-613</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283152</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am Rev Respir Dis. 1991 Jul;144(1):95-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2064145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>EBioMedicine. 2020 Jul;57:102833</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32574956</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Medicine (Baltimore). 2018 Nov;97(45):e13087</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30407312</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 1994 Nov;106(5):1517-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7956413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2019 Oct 1;322(13):1261-1270</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31573637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Cell Cardiol. 2020 Jul;144:63-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32422320</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2000 Jul;162(1):225-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10903246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2020 May 22;16(5):e1008536</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32442210</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E65 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E65 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32810081
   |texte=   Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32810081" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.

Airway Hygiene in COVID-19 Pneumonia: Treatment Responses of 3 Critically Ill Cruise Ship Employees.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki